The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2025Enhancing Recruitment of Individuals Traditionally Underrepresented in Parkinson’s Disease Research into the SPARX3 Clinical Trial
Study Rationale: SPARX3 is a Phase 3 clinical trial designed to assess whether high intensity aerobic exercise can delay progression of Parkinson’s disease (PD) better than does moderate intensity...
-
Research Grant, 2025Construction of a Living Library of Digital Technologies for Use in Research and Care of Parkinson’s Disease.
Study Rationale: Interest in digital technologies within Parkinson’s disease (sensors, devices, specific smartphone apps) for early detection and disease monitoring has increased in recent years. Over...
-
Research Grant, 2025Identifying Protein Changes Associated with Parkinson’s Disease: Proteomics Public Data Compilation
Study Rationale: Accumulation of toxic protein aggregates is a hallmark of neurodegenerative disorders that include Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA)...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers, 2025Development of an Assay for Rapid Detection of Activated LRRK2
Study Rationale: Mutations associated with Parkinson’s disease (PD) elevate the activity of a protein called Leucine-rich repeat kinase 2 (LRRK2). Kinases add phosphate groups to other proteins and to...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024A Novel Brain-penetrating Antibody for Treating Parkinson’s Disease
Study Rationale: Inflammation in the brain is an important trigger of Parkinson’s disease (PD). Our strategy is to block one of the key molecules mediating inflammation and degeneration in the brain...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024IND-enabling Studies of a Molecule that Enhances Mitophagy as Disease-modifying Therapy for Parkinson's Disease
Study Rationale: Studies show that Parkinson's disease (PD) is frequently associated with damage to mitochondria, structures that provide cells with the energy they need to function. In particular, a...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.